Researchers analyzed patients with BE, excluding those with conditions that affect overall survival, diagnosed from 2004 to 2009 at Veterans Affairs hospitals. Patients diagnosed with esophageal adenocarcinoma after BE diagnosis were identified through 2011.
Of the 29,536 patients with BE, 424 patients developed esophageal adenocarcinoma during a mean follow-up of five years.
Here are three insights:
1. A total of 209 (49.3 percent) patients with esophageal adenocarcinoma were in BE surveillance programs and were diagnosed using surveillance endoscopy.
2. The surveillance endoscopy patients were more likely to be diagnosed at an early stage, survive longer and have lower cancer-related mortality than those diagnosed without surveillance endoscopy.
3. Surveillance endoscopy among patients with BE was associated with a decreased risk of esophageal adenocarcinoma-related death.
More articles on GI/endoscopy:
HCV treatment costs range from $83k to $150k: 4 key insights on the lack of access to care
3 GI physicians in the news — July 15, 2016
ASGE names Dr. Kenneth McQuaid president, 2016-2017 board: 4 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.